Shenyang Xingqi Pharmaceutical (300573) Stock Overview

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People's Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products. It also engages in the technology development, technical consultation, investment, and eye hospital businesses, as well as production and wholesale of pharmaceuticals. The company was founded in 1977 and is headquartered in Shenyang, the People's Republic of China.